Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Myelodysplastic Neoplasms Patients' and Caregivers' Unmet Needs and Their Impact on Their Quality of Life and Symptoms

Blood (2024) 144 (Supplement 1): 3800.

https://doi.org/10.1182/blood-2024-210768

Published: 2024

Journal Articles

Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry

Blood (2022) 140 (Supplement 1): 1498–1500.

https://doi.org/10.1182/blood-2022-159993

Published: 2022

Journal Articles

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)

Luca Lanino, Prassede Salutari, Alessandra Perego, Bruno Fattizzo, Marta Riva, Marta Ubezio, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Maria Teresa Voso, Anna Maria Pelizzari, Antonella Poloni, Isabella Capodanno, Chiara Elena, Claudio Fozza, Fabrizio Pane, Massimo Breccia, Marco De Gobbi, Francesco Di Bassiano, Daniela Barraco, Elena Crisà, Dario Ferrero, Chiara Frairia, Antonella Vaccarino, Davide Griguolo, Stefania Paolini, Martina Quintini, Mariarosaria Sessa, Mauro Turrini, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Cristina Foli, Alfredo Molteni, Ubaldo Occhini, Giulia Rivoli, Carmine Selleri, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Alessandro Rambaldi, Ilaria Tanasi, Patrizia Tosi, Ilaria Naldi, Valeria Santini, Matteo G. Della Porta

Blood (2022) 140 (Supplement 1): 6945–6948.

https://doi.org/10.1182/blood-2022-164559

Published: 2022

Journal Articles

Impact of Bone Marrow Fibrosis Grade in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis. a Study of the Mysec Group

Blood (2019) 134 (Supplement_1): 2946.

https://doi.org/10.1182/blood-2019-124854

Published: 2019

Journal Articles

Solid Tumors in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: A Study on 2220 Patients

Blood (2018) 132 (Supplement 1): 3039.

https://doi.org/10.1182/blood-2018-99-115318

Published: 2018

Journal Articles

The Anatomy of Recurrent Thrombosis and Its Risk Factors in Myeloproliferative Neoplasms

Silvia Betti, MD, Daniela Barraco, MD, Mythri Mudireddy, MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2017) 130 (Supplement 1): 4190.

https://doi.org/10.1182/blood.V130.Suppl_1.4190.4190

Published: 2017

Journal Articles

Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases

Silvia Betti, MD, Daniela Barraco, MD, Mythri Mudireddy, MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2017) 130 (Supplement 1): 1645.

https://doi.org/10.1182/blood.V130.Suppl_1.1645.1645

Published: 2017

Journal Articles

Momelotinib Therapy in Myelofibrosis: 6-Years Follow-up Data on Safety, Efficacy and the Impact of Mutations on Overall and Relapse-Free Survival

Ayalew Tefferi, MD, Daniela Barraco, MD, Terra L. Lasho, PhD, Kebede H. Begna, MD, Aref Al-Kali, MD, William J. Hogan, MBChB, Mark R Litzow, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS, PhD

Blood (2016) 128 (22): 1123.

https://doi.org/10.1182/blood.V128.22.1123.1123

Published: 2016

Journal Articles

Gene Expression Profiling Identifies Distinct Signatures for Dysplastic and Proliferative Chronic Myelomonocytic Leukemia

Mrinal M Patnaik, MBBS, Daniela Barraco, MD, Terra L. Lasho, PhD, Ezequiel Tolosa, PhD, Luciana L. Almada, PhD, Jaime I Davila, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Éric Solary, MD PhD, Nathalie M. Droin, PhD, Naseema Gangat, MBBS, Aref Al-Kali, MD, Martin E. Fernandez-Zapico, MD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 110.

https://doi.org/10.1182/blood.V128.22.110.110

Published: 2016

Journal Articles

Identification of Serum Lactate Dehydrogenase (LDH) As an Independent Prognostic Biomarker in Polycythemia Vera

Ayalew Tefferi, MD, Daniela Barraco, MD, Sonia Cerquozzi, MD, Terra L. Lasho, PhD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS

Blood (2016) 128 (22): 3111.

https://doi.org/10.1182/blood.V128.22.3111.3111

Published: 2016

Journal Articles

Marked Elevation of Serum Lactate Dehydrogenase (LDH) in Primary Myelofibrosis: Clinical and Prognostic Correlates

Sahrish Shah, MBBS, Mythri Mudireddy, MBBS, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 3113.

https://doi.org/10.1182/blood.V128.22.3113.3113

Published: 2016

Journal Articles

Abnormal Karyotype and Prognosis in Polycythemia Vera: A Single Center Experience in 239 Informative Cases

Sonia Cerquozzi, MD, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 3115.

https://doi.org/10.1182/blood.V128.22.3115.3115

Published: 2016

Journal Articles

The Prognostic Relevance of Serum Lactate Dehydrogenase and Mild Reticulin Fibrosis in Essential Thrombocythemia

Mythri Mudireddy, MBBS, Daniela Barraco, MD, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 3120.

https://doi.org/10.1182/blood.V128.22.3120.3120

Published: 2016

Journal Articles

Prognostic Impact of Bone Marrow Fibrosis in Polycythemia Vera: Validation of the IWG-MRT Study and Additional Observations

Daniela Barraco, MD, Sonia Cerquozzi, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 3129.

https://doi.org/10.1182/blood.V128.22.3129.3129

Published: 2016

Journal Articles

Risk Factors for Arterial Versus Venous Thrombosis in Polycythemia Vera: Single Center Experience in 587 Patients

Sonia Cerquozzi, MD, Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 948.

https://doi.org/10.1182/blood.V128.22.948.948

Published: 2016

Journal Articles

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Aref Al-Kali, MD, Michelle Elliott, MD, Mark R. Litzow, MD, Naseema Gangat, MBBS, Curtis A. Hanson, MD, Ayalew Tefferi, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 1989.

https://doi.org/10.1182/blood.V128.22.1989.1989

Published: 2016

Journal Articles

Prefibrotic Versus Overtly Fibrotic Primary Myelofibrosis: Clinical, Cytogenetic, Molecular and Prognostic Comparisons

Mythri Mudireddy, MBBS, Sahrish Shah, MBBS, Terra L. Lasho, PhD, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4247.

https://doi.org/10.1182/blood.V128.22.4247.4247

Published: 2016

Journal Articles

U2AF1 Mutation Variants and Their Phenotypic and Prognostic Relevance in Primary Myelofibrosis

Ayalew Tefferi, MD, Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Sahrish Shah, MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD

Blood (2016) 128 (22): 4248.

https://doi.org/10.1182/blood.V128.22.4248.4248

Published: 2016

Journal Articles

Monocytosis Is a Powerful and Independent Predictor of Shortened Overall and Leukemia-Free Survival in Primary Myelofibrosis

Sahrish Shah, MBBS, Mythri Mudireddy, MBBS, Terra L. Lasho, PhD, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Michelle Elliott, MD, Animesh Pardanani, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4249.

https://doi.org/10.1182/blood.V128.22.4249.4249

Published: 2016

Journal Articles

Monocytosis in Polycythemia Vera: Clinical and Molecular Correlates

Daniela Barraco, MD, Sonia Cerquozzi, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4259.

https://doi.org/10.1182/blood.V128.22.4259.4259

Published: 2016

NARROW

Myelodysplastic Neoplasms Patients' and Caregivers' Unmet Needs and Their Impact on Their Quality of Life and Symptoms

Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry

Impact of Bone Marrow Fibrosis Grade in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis. a Study of the Mysec Group

Solid Tumors in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: A Study on 2220 Patients

The Anatomy of Recurrent Thrombosis and Its Risk Factors in Myeloproliferative Neoplasms

Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases

Momelotinib Therapy in Myelofibrosis: 6-Years Follow-up Data on Safety, Efficacy and the Impact of Mutations on Overall and Relapse-Free Survival

Gene Expression Profiling Identifies Distinct Signatures for Dysplastic and Proliferative Chronic Myelomonocytic Leukemia

Identification of Serum Lactate Dehydrogenase (LDH) As an Independent Prognostic Biomarker in Polycythemia Vera

Marked Elevation of Serum Lactate Dehydrogenase (LDH) in Primary Myelofibrosis: Clinical and Prognostic Correlates

Abnormal Karyotype and Prognosis in Polycythemia Vera: A Single Center Experience in 239 Informative Cases

The Prognostic Relevance of Serum Lactate Dehydrogenase and Mild Reticulin Fibrosis in Essential Thrombocythemia

Prognostic Impact of Bone Marrow Fibrosis in Polycythemia Vera: Validation of the IWG-MRT Study and Additional Observations

Risk Factors for Arterial Versus Venous Thrombosis in Polycythemia Vera: Single Center Experience in 587 Patients

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Prefibrotic Versus Overtly Fibrotic Primary Myelofibrosis: Clinical, Cytogenetic, Molecular and Prognostic Comparisons

U2AF1 Mutation Variants and Their Phenotypic and Prognostic Relevance in Primary Myelofibrosis

Monocytosis Is a Powerful and Independent Predictor of Shortened Overall and Leukemia-Free Survival in Primary Myelofibrosis

Monocytosis in Polycythemia Vera: Clinical and Molecular Correlates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only